Inès is a Research Scientist in Epitopea’s R&D team, where she supports the expansion of discovery workflows and the implementation of immunogenicity assays to advance the company’s vaccine design platform.

She brings experience across biotech and public research institutes in Europe and Canada, with a strong background in immuno-oncology, particularly T cell therapies and early-stage drug discovery. Through her roles in discovery and pre-clinical development, she has contributed to advancing immunotherapies from target discovery to IND-enabling studies.

Inès holds a diploma in biological engineering and is driven by a commitment to deliver impactful therapeutic solutions that improve patient outcomes.